Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 43(21): 3807-3824, 2023 05 24.
Article in English | MEDLINE | ID: mdl-37185099

ABSTRACT

Sphingosine-1-phosphate (S1P), a bioactive sphingolipid concentrated in the brain, is essential for normal brain functions, such as learning and memory and feeding behaviors. Sphingosine kinase 1 (SphK1), the primary kinase responsible for S1P production in the brain, is abundant within presynaptic terminals, indicating a potential role of the SphK1/S1P axis in presynaptic physiology. Altered S1P levels have been highlighted in many neurologic diseases with endocytic malfunctions. However, it remains unknown whether the SphK1/S1P axis may regulate synaptic vesicle endocytosis in neurons. The present study evaluates potential functions of the SphK1/S1P axis in synaptic vesicle endocytosis by determining effects of a dominant negative catalytically inactive SphK1. Our data for the first time identify a critical role of the SphK1/S1P axis in endocytosis in both neuroendocrine chromaffin cells and neurons from mice of both sexes. Furthermore, our Ca2+ imaging data indicate that the SphK1/S1P axis may be important for presynaptic Ca2+ increases during prolonged stimulations by regulating the Ca2+ permeable TRPC5 channels, which per se regulate synaptic vesicle endocytosis. Collectively, our data point out a critical role of the regulation of TRPC5 by the SphK1/S1P axis in synaptic vesicle endocytosis.SIGNIFICANCE STATEMENT Sphingosine kinase 1 (SphK1), the primary kinase responsible for brain sphingosine-1-phosphate (S1P) production, is abundant within presynaptic terminals. Altered SphK1/S1P metabolisms has been highlighted in many neurologic disorders with defective synaptic vesicle endocytosis. However, whether the SphK1/S1P axis may regulate synaptic vesicle endocytosis is unknown. Here, we identify that the SphK1/S1P axis regulates the kinetics of synaptic vesicle endocytosis in neurons, in addition to controlling fission-pore duration during single vesicle endocytosis in neuroendocrine chromaffin cells. The regulation of the SphK1/S1P axis in synaptic vesicle endocytosis is specific since it has a distinguished signaling pathway, which involves regulation of Ca2+ influx via TRPC5 channels. This discovery may provide novel mechanistic implications for the SphK1/S1P axis in brain functions under physiological and pathologic conditions.


Subject(s)
Phosphotransferases (Alcohol Group Acceptor) , Synaptic Vesicles , Male , Female , Mice , Animals , Synaptic Vesicles/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Sphingosine/metabolism , Endocytosis , Lysophospholipids/metabolism , TRPC Cation Channels
2.
Elife ; 102021 09 27.
Article in English | MEDLINE | ID: mdl-34569930

ABSTRACT

Transient receptor potential melastatin 7 (TRPM7) contributes to a variety of physiological and pathological processes in many tissues and cells. With a widespread distribution in the nervous system, TRPM7 is involved in animal behaviors and neuronal death induced by ischemia. However, the physiological role of TRPM7 in central nervous system (CNS) neuron remains unclear. Here, we identify endocytic defects in neuroendocrine cells and neurons from TRPM7 knockout (KO) mice, indicating a role of TRPM7 in synaptic vesicle endocytosis. Our experiments further pinpoint the importance of TRPM7 as an ion channel in synaptic vesicle endocytosis. Ca2+ imaging detects a defect in presynaptic Ca2+ dynamics in TRPM7 KO neuron, suggesting an importance of Ca2+ influx via TRPM7 in synaptic vesicle endocytosis. Moreover, the short-term depression is enhanced in both excitatory and inhibitory synaptic transmissions from TRPM7 KO mice. Taken together, our data suggests that Ca2+ influx via TRPM7 may be critical for short-term plasticity of synaptic strength by regulating synaptic vesicle endocytosis in neurons.


Subject(s)
Endocytosis , Neural Inhibition , Neuronal Plasticity , Neurons/metabolism , Synaptic Transmission , Synaptic Vesicles/metabolism , TRPM Cation Channels/metabolism , Animals , Calcium/metabolism , Calcium Signaling , Chromaffin Cells/metabolism , Excitatory Postsynaptic Potentials , Female , HEK293 Cells , Humans , Inhibitory Postsynaptic Potentials , Kinetics , Male , Mice, Knockout , Synaptic Vesicles/genetics , TRPM Cation Channels/genetics
3.
J Neurochem ; 152(1): 48-60, 2020 01.
Article in English | MEDLINE | ID: mdl-31587282

ABSTRACT

Phosphatidylserine (PS), a negatively charged phospholipid present predominantly at the inner leaflet of the plasma membrane, has been widely implicated in many cellular processes including membrane trafficking. Along this line, PS has been demonstrated to be important for endocytosis, however, the involved mechanisms remain uncertain. By monitoring clathrin-mediated endocytosis (CME) of single vesicles in mouse chromaffin cells using cell-attached capacitance measurements that offer millisecond time resolution, we demonstrate in the present study that the fission-pore duration is reduced by PS addition, indicating a stimulatory role of PS in regulating the dynamics of vesicle fission during CME. Furthermore, our results show that the PS-mediated effect on the fission-pore duration is Ca2+ -dependent and abolished in the absence of synaptotagmin 1 (Syt1), implying that Syt1 is necessary for the stimulatory role of PS in vesicle fission during CME. Consistently, a Syt1 mutant with a defective PS-Syt1 interaction increases the fission-pore duration. Taken together, our study suggests that PS-Syt1 interaction may be critical in regulating fission dynamics during CME.


Subject(s)
Chromaffin Cells/physiology , Clathrin-Coated Vesicles/physiology , Clathrin/physiology , Phosphatidylserines/physiology , Animals , Cells, Cultured , Endocytosis/physiology , Exocytosis/physiology , Female , Gene Knockout Techniques , Male , Mice , Mice, Inbred C57BL , Synaptotagmin I/genetics , Synaptotagmin I/physiology
4.
J Neurochem ; 149(6): 729-746, 2019 06.
Article in English | MEDLINE | ID: mdl-30963576

ABSTRACT

Sphingosine-1-phosphate (S1P) is an essential bioactive sphingosine lipid involved in many neurological disorders. Sphingosine kinase 1 (SphK1), a key enzyme for S1P production, is concentrated in presynaptic terminals. However, the role of S1P/SphK1 signaling in exocytosis remains elusive. By detecting catecholamine release from single vesicles in chromaffin cells, we show that a dominant negative SphK1 (SphK1DN ) reduces the number of amperometric spikes and increases the duration of foot, which reflects release through a fusion pore, implying critical roles for S1P in regulating the rate of exocytosis and fusion pore expansion. Similar phenotypes were observed in chromaffin cells obtained from SphK1 knockout mice compared to those from wild-type mice. In addition, extracellular S1P treatment increased the number of amperometric spikes, and this increase, in turn, was inhibited by a selective S1P3 receptor blocker, suggesting extracellular S1P may regulate the rate of exocytosis via activation of S1P3. Furthermore, intracellular S1P application induced a decrease in foot duration of amperometric spikes in control cells, indicating intracellular S1P may regulate fusion pore expansion during exocytosis. Taken together, our study represents the first demonstration that S1P regulates exocytosis through distinct mechanisms: extracellular S1P may modulate the rate of exocytosis via activation of S1P receptors while intracellular S1P may directly control fusion pore expansion during exocytosis. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.


Subject(s)
Chromaffin Cells/metabolism , Exocytosis/physiology , Lysophospholipids/metabolism , Sphingosine/analogs & derivatives , Animals , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Sphingosine/metabolism
5.
Br J Pharmacol ; 172(10): 2479-92, 2015 May.
Article in English | MEDLINE | ID: mdl-25573619

ABSTRACT

BACKGROUND AND PURPOSE: Schizandrin (SCH) has been reported to prevent or reduce learning and memory defects. However, it is not known whether SCH ameliorates cognitive impairments induced by oestrogen deficiency. In the present study, we investigated the effect of SCH on memory in ovariectomized (OVX) and non-OVX rats. EXPERIMENTAL APPROACH: A passive avoidance test was used to evaluate the effect of SCH on memory. Field EPSPs were recorded in hippocampal slices using an electrophysiological method. In OVX rats, biochemical parameters in the bilateral hippocampus were measured; these included superoxide dismutase (SOD), malondialdehyde (MDA) and AChE. Also, the number of NADPH-diaphorase (NADPH-d) positive neurons was counted by NADPH-d histochemistry staining technique. KEY RESULTS: Oral SCH improved the memory and facilitated the induction of long-term potentiation in non-OVX and OVX rats; this effect was more obvious in OVX rats. Similarly, SCH perfusion enhanced synaptic transmission in hippocampal slices from both non-OVX and OVX rats. However, SCH perfusion reduced the ratio of paired-pulse facilitation only in OVX but not in non-OVX rats. In addition, SCH decreased AChE activity and MDA level and increased SOD activity and the number of NADPH-d-positive neurons in OVX rats. CONCLUSIONS AND IMPLICATIONS: SCH improves memory in OVX rats and its potential mechanisms may include a reduction in the loss of hippocampal NADPH-d positive neurons, an increase of antioxidant properties and a potentiation of synaptic transmission that possibly involves to enhance cholinergic function. Overall, our findings indicate that SCH has potential as a therapeutic strategy for the cognitive dysfunctions associated with the menopause.


Subject(s)
Cyclooctanes/pharmacology , Cyclooctanes/therapeutic use , Hippocampus/drug effects , Lignans/pharmacology , Lignans/therapeutic use , Memory Disorders/drug therapy , Ovariectomy/adverse effects , Polycyclic Compounds/pharmacology , Polycyclic Compounds/therapeutic use , Synaptic Transmission/drug effects , Acetylcholinesterase/metabolism , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Avoidance Learning/drug effects , Cell Count , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Female , GPI-Linked Proteins/metabolism , Hippocampus/anatomy & histology , Hippocampus/metabolism , Hippocampus/physiology , Long-Term Potentiation/drug effects , Malondialdehyde/metabolism , Memory Disorders/chemically induced , Rats , Superoxide Dismutase/metabolism
6.
Eur J Pharmacol ; 714(1-3): 249-53, 2013 Aug 15.
Article in English | MEDLINE | ID: mdl-23819912

ABSTRACT

Cordycepin (3'-deoxyadenosine) is the major bioactive component of Cordyceps militaris that has been widely used in oriental countries as a Traditional Chinese Medicine and healthy food for preventing early aging, improving physical performance and increasing lifespan. Cordyceps militaris extracts other than cordycepin have been reported to improve cognitive function. Although cordycepin is one of the most utilized Cordyceps militaris components, it remains unknown whether cordycepin could improve learning and memory. Here we investigated effects of cordycepin on learning and memory in healthy and ischemic mice using Y-maze test. We found that oral cordycepin administration at dose of 10 mg/kg significantly improved Y-maze learning performance both in healthy and ischemic mice. However, cordycepin at dose of 5 mg/kg enhanced Y-maze learning only in ischemic mice but not healthy mice. In this study, simultaneously, we found that orally administrated cordycepin significantly decreased the neuronal loss induced by ischemia in hippocampal CA1 and CA3 regions. Collectively, our results can provide valuable evidence that cordycepin may act as a nootropic product or potential clinical application in improving cognitive function of patients with ischemic stroke in the future.


Subject(s)
Deoxyadenosines/pharmacology , Maze Learning/drug effects , Nootropic Agents/pharmacology , Animals , Brain Ischemia/pathology , Brain Ischemia/physiopathology , Cognition/drug effects , Dose-Response Relationship, Drug , Hippocampus/pathology , Male , Mice , Neurons/drug effects , Neurons/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...